The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 02, 2018
Filed:
May. 03, 2016
Applicant:
Omeros Corporation, Seattle, WA (US);
Inventors:
Gregory A. Demopulos, Mercer Island, WA (US);
Jeffrey M. Herz, Mill Creek, WA (US);
Wayne R. Gombotz, Kenmore, WA (US);
Hui-rong Shen, Bothell, WA (US);
Assignee:
Omeros Corporation, Seattle, WA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4422 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/00 (2006.01); A61K 31/192 (2006.01); A61K 31/40 (2006.01); A61K 31/44 (2006.01); A61K 31/455 (2006.01); A61L 31/16 (2006.01); A61K 31/21 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4422 (2013.01); A61K 9/0034 (2013.01); A61K 9/08 (2013.01); A61K 31/00 (2013.01); A61K 31/192 (2013.01); A61K 31/21 (2013.01); A61K 31/40 (2013.01); A61K 31/44 (2013.01); A61K 31/455 (2013.01); A61L 31/16 (2013.01); A61L 2300/402 (2013.01); A61L 2300/41 (2013.01); A61L 2300/432 (2013.01);
Abstract
Compositions of a cyclooxygenase inhibitor and a calcium channel antagonist in a liquid carrier. The composition may be administered the urinary tract during urological diagnostic, interventional, surgical and other medical procedures. One disclosed composition comprises ketoprofen and nifedipine in a liquid irrigation carrier, and includes a solubilizing agent, stabilizing agents and a buffering agent.